Canadian Online Pharmacy

CDER New April 2, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

April 1, 2013


New and Generic Drug Approvals

March 29, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Brilinta ticagrelor Tablet; Oral Astrazeneca Lp Labeling Revision
Foradil formoterol fumarate Powder; Inhalation Novartis Labeling Revision
Invokana canagliflozin Tablet; Oral Janssen Res and Dev Approval
Salonpas menthol; methyl salicylate Patch; Topical Hisamitsu Pharm Co Efficacy Supplement with Clinical Data to Support
Tramadol Hydrochloride tramadol hydrochloride Tablet; Oral Cspc Ouyi Pharma Co Ltd Approval
Venofer iron sucrose Injectable; Intravenous Luitpold Manufacturing Change or Addition
Vesicare solifenacin succinate Tablet; Oral Astellas Labeling Revision
Voraxaze glucarpidase Injectable; Injection Btg International Inc Labeling Revision
Zoledronic Acid zoledronic acid Injectable; Injection Dr Reddys Labs Ltd Approval
Zoledronic Acid zoledronic acid Injectable; Injection Emcure Pharms Ltd Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery